Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
Siglec-9 is an MHC-independent inhibitory receptor expressed on a subset of natural killer (NK) cells. Siglec-9 restrains NK cytotoxicity by binding to sialoglycans (sialic acid-containing glycans) on target cells. Despite the importance of Siglec-9 interactions in tumor immune evasion, their role a...
Guardado en:
Autores principales: | Opeyemi S Adeniji, Leticia Kuri-Cervantes, Chenfei Yu, Ziyang Xu, Michelle Ho, Glen M Chew, Cecilia Shikuma, Costin Tomescu, Ashley F George, Nadia R Roan, Lishomwa C Ndhlovu, Qin Liu, Kar Muthumani, David B Weiner, Michael R Betts, Han Xiao, Mohamed Abdel-Mohsen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7893d0635c944c17b3235ba1b247de02 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells
por: Opeyemi S. Adeniji, et al.
Publicado: (2021) -
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Hyeree Choi, et al.
Publicado: (2021) -
Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
por: Sulayman Benmerzoug, et al.
Publicado: (2021) -
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Ernesto Rodriguez, et al.
Publicado: (2021) -
Siglecs as Therapeutic Targets in Cancer
por: Jackwee Lim, et al.
Publicado: (2021)